What in silico modelling can offer opponents before the EPO
Marion Autissier, Denis Bourgarel
Artificial intelligence and biotechnology: challenging an in silico invention
The first two articles in this series took the applicant’s perspective: how the EPO assesses in (...)
Practical advice on patent strategy in the pharmaceutical and biotech sectors
Marion Autissier, Denis Bourgarel
Protecting inventions developed in silico
Our first article showed that in silico modelling is now becoming a feature of biomedical patent (...)
Fabrice Bircker, Stéphane Millet
Reveal Day des 1615 candidatures pour la création de nouvelles extensions Internet
As we recently announced in our article, 1,616 New Internet Extensions Coming Soon: Are You (...)
Fabrice Bircker, Stéphane Millet
1616 nouvelles extensions Internet bientôt dévoilées, êtes-vous concerné ?
An analysis of the 1,616 applications for new Internet extensions will be essential as soon as they (...)
Pharma and biotech: the patentability of in silico inventions before the EPO
Marion Autissier, Denis Bourgarel
New pharmaceutical molecules, new clinical protocols: what impact does in silico have on patentability in biotechnology?
When modeling replaces the laboratory in the biomedical field An “in silico” invention is an (...)
Sandrine Bouvier-Ravon, François Jonquères
The Doctrine of Equivalents in France
A year ago, Sandrine Bouvier-Ravon and François Jonquères, partners at Plasseraud IP Avocats, co- (...)
Bruno Loubet
Design processes, simulation and technical effect: decision T 0799/24 clarifies the requirements for patentability at the EPO
T0799/24 “JFESteel”: an explicit manufacturing step is not mandatory to provide a technical effect (...)
Bruno Loubet
Sufficiency of disclosure and Artificial Intelligence: lessons from decision T 0048/24 (EBARA)
One of the key requirements that a European application must fulfill is the criterion of (...)
Bruno Loubet
Méthodes d’affaires et brevetabilité à l’OEB : l’homme du business fictif à l’épreuve de la décision T 1392/20
At the European Patent Office (EPO), computer-implemented inventions, especially those involving (...)
Lilia Leghmizi
On 27 June 2023, in case T 438/19, Technical Board 3.3.03 referred key questions to the Enlarged (...)
Bruno Loubet
T 1580/23 : la seule mention d'une norme de télécommunication dans la description d'un brevet européen ne suffit pas à revendiquer un effet relatif à la mise en œuvre de la norme
The decision T 1580/23 of the Boards of Appeal 3.5.05 of the European Patent Office (EPO) is an (...)
Nadine Rocaboy, Oung-Heng Heng
G 1/24 Claim Interpretation at the EPO: No Legal Anchor, but a Clear(er?) Path Forward
The Enlarged Board of Appeal’s recent decision in G 1/24 has provided significant clarification (...)